Cefuroxime
Cefuroxime Aristo contains the active substance cefuroxime. It is an antibiotic used in adults and children. The medicine works by killing the bacteria that cause infections. It belongs to a group of medicines called cephalosporins.
Cefuroxime Aristo is used to treat infections of:
Cefuroxime Aristo may also be used:
Your doctor may perform tests to determine the type of bacteria causing the infection and to check if the bacteria are sensitive to Cefuroxime Aristo during treatment.
If any of these apply to you, do not take Cefuroxime Aristo until you have consulted your doctor.
Before taking Cefuroxime Aristo, discuss it with your doctor or pharmacist.
Severe skin reactions have occurred with cefuroxime treatment, such as:
Stevens-Johnson syndrome, toxic epidermal necrolysis, and drug reaction with eosinophilia and systemic symptoms (DRESS). If you notice any symptoms related to severe skin reactions described in section 4, seek medical advice immediately.
Cefuroxime Aristo is not recommended for use in children under 3 months of age, as the safety and efficacy of the medicine in this age group are not known.
During treatment with Cefuroxime Aristo, attention should be paid to whether the following complaints occur: allergic reactions, fungal infections (e.g. thrush), and severe diarrhea (pseudomembranous colitis). This will reduce the risk of complications. See "Complaints to watch out for" in section 4.
Cefuroxime Aristo may affect the results of blood tests for sugar and a blood test called the Coombs test. If you are going to have blood tests:
tell the person taking the blood sample that you are taking Cefuroxime Aristo.
Tell your doctor or pharmacist about all medicines you are taking, have recently taken, or might take.
Medicines that reduce stomach acid (e.g. antacids) may affect the action of Cefuroxime Aristo.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Do not take this medicine during pregnancy and breastfeeding, unless your doctor has explicitly advised you to do so.
If the breastfed child experiences gastrointestinal problems (diarrhea, fungal infections) or rashes, breastfeeding should be discontinued and medical advice should be sought immediately.
Cefuroxime Aristo may cause dizziness and other side effects that may impair your alertness.
Do not drive or operate machinery if you do not feel well.
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means it is considered "sodium-free".
You should discuss with your doctor whether Cefuroxime Aristo is suitable for you.
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist.
Recommended dose
The usual dose of Cefuroxime Aristo is 250 mg to 500 mg twice daily, depending on the severity and type of infection.
The usual dose of Cefuroxime Aristo is 10 mg/kg body weight (not more than 125 mg) to 15 mg/kg body weight (not more than 250 mg) twice daily, depending on:
Cefuroxime Aristo is not recommended for use in children under 3 months of age, as the safety and efficacy of the medicine in this age group are not known.
Depending on the disease and how the patient responds to treatment, the initial dose may be changed or more than one treatment cycle may be necessary.
If you have kidney problems, your doctor may change the dose of Cefuroxime Aristo.
Tell your doctor if this applies to you.
Method of administration
Oral use.
Cefuroxime Aristo should be taken after a meal. This will increase the effectiveness of the treatment.
The tablets should be swallowed whole with water.
[only for 250 mg strength]
The tablet can be divided into two equal parts.
The tablets should not be crushed or chewed.
If you take more Cefuroxime Aristo than prescribed, you may experience neurological disorders, in particular, the risk of seizures (epileptic fits) increases.
Seek medical advice immediately. If possible, show the packaging of Cefuroxime Aristo.
Do not take a double dose to make up for a forgotten dose. Take the next dose at the usual time.
Do not stop taking Cefuroxime Aristo without consulting your doctor.
It is important to complete the full treatment cycle with Cefuroxime Aristo. Do not stop treatment, unless your doctor advises you to do so – even if you feel better. If you do not complete the full treatment cycle, the infection may return.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Cefuroxime Aristo can cause side effects, although not everybody gets them.
In a small number of patients taking Cefuroxime Aristo, an allergic reaction or potentially severe skin reaction has been reported. The symptoms may be:
If you experience any of these symptoms, seek medical advice immediately.
May affect up to 1 in 10 people:
Common side effects that may be seen in blood tests:
May affect up to 1 in 100 people:
Uncommon side effects that may be seen in blood tests:
Other side effectsOther side effects occur in a very small number of patients, but the exact frequency is unknown:
Side effects that may be seen in blood tests:
If you experience any side effects, including those not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Jerozolimskie Avenue 181 C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of this medicine.
Keep out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the blister and carton after EXP. The expiry date refers to the last day of the month.
Do not store above 25°C.
Store in the original package to protect from light.
Do not use Cefuroxime Aristo if the tablets are cracked or show other visible signs of damage.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
[250 mg]
White to almost white, round, biconvex film-coated tablets with a diameter of 11 mm and a dividing line.
The tablets are packaged in PVC/PVDC/Aluminum blisters.
Pack sizes: 10, 12, 14, 16, 20, and 24 film-coated tablets.
The tablet can be divided into two equal doses.
[500 mg]
White to almost white, oval, biconvex film-coated tablets with dimensions of 9 mm x 18.5 mm.
The tablets are packaged in PVC/PVDC/Aluminum blisters.
Pack sizes: 10, 12, 14, 16, 20, and 24 film-coated tablets.
Not all pack sizes may be marketed.
Marketing authorization holder
Aristo Pharma Sp. z o.o.
Baletowa Street 30
02-867 Warsaw
phone: +48 22 855 40 93
Manufacturer
Aristo Pharma GmbH
Wallenroder Strasse 8-10
13435 Berlin
Germany
Belgium
Cefuroxime Aristo
France
Cefuroxime Aristo
Germany
Cefuroxim Aristo
Poland
Cefuroxime Aristo
Portugal
Cefuroxima Aristo Pharma
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.